In recent days two documents were published, well representing the actual vision of several regulatory bodies towards electronic cigarette, and that can help us to outline the evolution of the vaping regulatory scenario.
At the end of May the “World No Tobacco Day”was celebrated; this project was set up by the World Health Organization (WHO) back in 1988 and since then it has been held annually aiming to highlight the risks associated with the consumption of tobacco and to promote effective policies to fight it, through numerous initiatives organized all over the world.
Each edition of this event represents an opportunity to discuss the data about the use of tobacco in the world and to investigate a specific related problem. This year’s focus was the close link between tobacco and cardiovascular disease. The information material provided by the WHO clearly and effectively describes how tobacco is an important risk factor for heart attack, stroke and other cardio-vascular diseases, and reports of alarming statistical data and various scientific references.
As related tobacco products, ENDSs have also been considered in these analyses. Although recognizing that ENDSs contain far fewer toxic substances than traditional cigarette as the evidences revealed so far, it’s also emphasized that the long-term effects of ENDS are not yet known, as well as their possible contribution to the emerge of cardiovascular diseases because of nicotine and the jeopardy for those indirectly exposed to the emitted vapour.
Several WHO-stimulated discussions took place worldwide; one of our experts was present at the one held by the Italian Istituto Superiore di Sanità in Rome, where it was emphasized that an effective strategy in the fight against smoking is an increase in the taxes on tobacco products.
It is therefore reasonable to expect, on the one hand, an increase in the prices of tobacco products to facilitate a reduction in consumption boosting a drift towards alternatives such as vaping, and on the other a progress in the proposal of a unified European tax on vaping products .
On the other side of the Atlantic, the Food and Drug Administration (FDA) published early June the “2017 National Youth Tobacco Survey“, conducted by the CDC (Centers for Disease Control and Prevention) which shows a decline in the consumption of tobacco in its entirety, but an increase in the spread of electronic cigarette, both in secondary and high schools, for the fourth year in row.
The same document also recalls how the rates of use of tobacco in young people, and in particular the use of electronic cigarettes, continue to be a source of concern for the FDA, which announced a plan for the prevention of smoking in youth, involving a series of strong contrasting actions and campaigns to avoid the access by young people to tobacco products, including e-cigarettes.
In consideration of these definite positions, it’s appropriate and advantageous for companies in the sector to understand what the US authorities intend to hinder and to inaugurate the necessary actions not to be unprepared for an announced revolution.